Skip to main content

Table 4 Multivariate analysis

From: Circulating tumor cells in newly diagnosed inflammatory breast cancer

Variable PFS OS
HR (95% CI) P value HR (95% CI) P value
ER/PR status 0.630 0.051 0.468 0.004
Positive for either versus negative for both (0.400 - 1.002) (0.279 - 0.785)
HER2 status 0.309 <0.001 0.268 <0.001
Overexpressed versus negative (0.173 - 0.554) (0.138 - 0.521)
Sites of metastases 1.536 0.143 2.319 0.002
Visceral versus nonvisceral (0.865 - 2.729) (1.364 - 3.942)
Stage 2.939 <0.001 1.681 0.131
mIBC versus stage III (1.818 – 4.750) (0.857 – 3.298)
Baseline CTCs count 1.621 0.044 1.995 0.008
≥5 versus <5 (1.014 - 2.591) (1.202 - 3.309)